Primary Fibrillary Glomerulonephritis in an Older Patient with Immunosuppression Challenges (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #PUB143; "Primary FGN has demonstrated variable responsiveness to immunosuppression, including rituximab, in several case series, but treatment in older adults is complicated by infection risk and comorbidities...DNAJB9 staining provided diagnostic certainty, but frailty, infectious complications, and limited therapeutic windows constrained management. This case highlights the need for individualized risk–benefit assessment and the development of safer, targeted therapies for older adults with primary FGN."
Clinical • Chronic Kidney Disease • Fibrosis • Glomerulonephritis • Immunology • Infectious Disease • Lupus Nephritis • Monoclonal Gammopathy • Nephrology • Novel Coronavirus Disease • Pneumonia • Renal Disease • Respiratory Diseases • Varicella Zoster
|
|
Muhammad Raza; Maria Tahir; Mahwash Siddiqi; Rafael Portela-Colon
|